Search

This paper presents and explains the principle behind anelectrochemical method to enhance the antimicrobial action of plasma‐activated hydrogel therapy (PAHT) in the context of wound decontamination. The process involves grounding and hydratingpoly(vinyl alcohol) (PVA) hydrogel films during treatment with a helium (He) plasma jet. This electrochemically enhances production of hydrogen peroxide (H2O2), which is amajor antibacterial agent produced in the PVA hydrogel. Production of H2O2 is shownto be electrically enhanced through electron dissociation reactions, and through reactions associated with excited state species, metastables and ultra‐violet (UV) photolysis. H2O2 production is chemically enhanced through the He flow of the plasma jet dehydrating the PVA hydrogel, which fuels the electrochemical dependent reactions associated with H2O2 production. The electrochemical process produces an unprecedented 3.4 mM of H2O2 in the PVA hydrogel. Production of other molecules such as reactive nitrogen species (RNS) are also enhanced by the same method. The electrochemically enhanced PAHT is highly effective ateradicating common wound pathogens Escherichia coli and Pseudomonas aeruginosa and mildly effective against Staphylococcus aureus. Overall, this study shows that the new PAHT dressing offers a promising alternative to antibiotics and silver‐based dressings for controlling infection and stimulating healing in wounds. [ABSTRACT FROM AUTHOR]

Introduction: We aim to explore potentials and modalities of cold atmospheric pressure plasma (CAP) for the subsequent development of therapies targeting an increased perfusion of the lower leg skin tissue. In this study, we addressed the question whether the microcirculation enhancement is restricted to the tissue in direct contact with plasma or if adjacent tissue might also benefit. Methods: A dielectric barrier discharge (DBD)-generated CAP device exhibiting an electrode area of 27.5 cm2 was used to treat the anterior lower leg of ten healthy subjects for 4.5 min. Subsequently, hyperspectral imaging was performed to measure the tempospatially resolved characteristics of microcirculation parameters in superficial (up to 1 mm) and deeper (up to 5 mm) skin layers. Results: In the tissue area covered by the plasma electrode, DBD-CAP treatment enhances most of the perfusion parameters. The maximum oxygen saturation increase reached 8%, the near-infrared perfusion index (NIR) increased by a maximum of 4%, and the maximum tissue hemoglobin increase equaled 14%. Tissue water index (TWI) was lower in both the control and the plasma groups, thus not affected by the DBD-CAP treatment. Yet, our study reveals that adjacent tissue is hardly affected by the enhancements in the electrode area, and the effects are locally confined. Conclusion: Application of DBD-CAP to the lower leg resulted in enhancement of cutaneous microcirculation that extended 1 h beyond the treatment period with localization to the tissue area in direct contact with the cold plasma. This suggests the possibility of tailoring application schemes for topically confined enhancement of skin microcirculation, e.g., in the treatment of chronic wounds. [ABSTRACT FROM AUTHOR]

Skin regeneration is a quite complex process. Epidermal differentiation alone takes about 30 days and is highly regulated. Wounds, especially chronic wounds, affect 2% to 3% of the elderly population and comprise a heterogeneous group of diseases. The prevailing reasons to develop skin wounds include venous and/or arterial circulatory disorders, diabetes, or constant pressure to the skin (decubitus). The hallmarks of modern wound treatment include debridement of dead tissue, disinfection, wound dressings that keep the wound moist but still allow air exchange, and compression bandages. Despite all these efforts there is still a huge treatment resistance and wounds will not heal. This calls for new and more efficient treatment options in combination with novel biocompatible skin scaffolds. Cold atmospheric pressure plasma (CAP) is such an innovative addition to the treatment armamentarium. In one CAP application, antimicrobial effects, wound acidification, enhanced microcirculations and cell stimulation can be achieved. It is evident that CAP treatment, in combination with novel bioengineered, biocompatible and biodegradable electrospun scaffolds, has the potential of fostering wound healing by promoting remodeling and epithelialization along such temporarily applied skin replacement scaffolds. [ABSTRACT FROM AUTHOR]

The article titled "Electrochemically Enhanced Antimicrobial Action of Plasma-Activated Poly(Vinyl Alcohol) Hydrogel Dressings" discusses the use of plasma-activated hydrogel therapy (PAHT) as a novel treatment for chronic wounds. PAHT involves the activation of hydrogels with reactive oxygen and nitrogen species (RONS) through ionized gas (plasma). The authors describe an electrochemical method to enhance the generation of RONS in hydrogels, resulting in a "super-charged" PAHT that effectively kills microbial wound pathogens and stimulates healing through oxidative stress and cellular signaling pathways. The study was conducted by a team of researchers and provides valuable insights into the potential of PAHT for wound treatment. [Extracted from the article]

The loss of skin integrity is inevitable in life. Wound healing is a necessary sequence of events to reconstitute the body's integrity against potentially harmful environmental agents and restore homeostasis. Attempts to improve cutaneous wound healing are therefore as old as humanity itself. Furthermore, nowadays, targeting defective wound healing is of utmost importance in an aging society with underlying diseases such as diabetes and vascular insufficiencies being on the rise. Because chronic wounds' etiology and specific traits differ, there is widespread polypragmasia in targeting non-healing conditions. Reactive oxygen and nitrogen species (ROS/RNS) are an overarching theme accompanying wound healing and its biological stages. ROS are signaling agents generated by phagocytes to inactivate pathogens. Although ROS/RNS's central role in the biology of wound healing has long been appreciated, it was only until the recent decade that these agents were explicitly used to target defective wound healing using gas plasma technology. Gas plasma is a physical state of matter and is a partially ionized gas operated at body temperature which generates a plethora of ROS/RNS simultaneously in a spatiotemporally controlled manner. Animal models of wound healing have been vital in driving the development of these wound healing-promoting technologies, and this review summarizes the current knowledge and identifies open ends derived from in vivo wound models under gas plasma therapy. While gas plasma-assisted wound healing in humans has become well established in Europe, veterinary medicine is an emerging field with great potential to improve the lives of suffering animals. [ABSTRACT FROM AUTHOR]

Introduction: Rosacea is a common, facial, chronic inflammatory skin disease. Due to its complex pathogenesis, adequate therapy of rosacea can be challenging. An innovative recent therapeutic tool is cold atmospheric plasma (CAP), which is already established in the treatment of chronic wounds and promising in different other skin diseases. Methods: In a split-face pilot study we investigated dielectric-barrier-discharged CAP in erythemato-telangiectatic (ETR) and/or papulopustular rosacea (PPR). CAP treatment was applied on lesional skin of a randomized side once daily (90 s/area) for 6 weeks. The other untreated side served as control. Co-primary endpoints were ≥1 improvement of the Investigator Global Assessment (IGA) score on the treated side compared to control and a decline of the Dermatology Life Quality Index (DLQI) after 6 weeks. Secondary endpoints included inflammatory lesion count (papules and pustules), skin redness intensity and erythema size. Adverse events (AEs) were recorded constantly. Additionally, participants were weekly assessed for symptoms, skin condition, trigger factors, skin care, treatment success, and local tolerance parameters. All p values were calculated using the Wilcoxon signed-rank test. Results: Twelve subjects (ETR, n = 3; ETR and PPR, n = 9) completed the study. DLQI was significantly improved after 6 weeks (p = 0.007). On the CAP-treated side, lesions (p = 0.007) and erythema size (p = 0.041) were significantly reduced compared to the control. IGA (p = 0.2) and skin redness intensity (p = 0.5) did not differ significantly between control and CAP-treated side. No serious AEs occurred and treatment was well tolerated. Conclusion: CAP is a promising new treatment of rosacea, especially for PPR. [ABSTRACT FROM AUTHOR]

Cold atmospheric plasmas are a known source of reactive species enabling various treatments, from the healing of chronic wounds to the treatment of surface cancers. Therapeutic endoscopic procedures require developing specific flexible tools that can be used through or alongside endoscopes. Plasma devices for endoscopy have aroused significant research interest over the past few decades, but their electrical behaviour is not yet fully understood and predictable. There is thus a clear need for a robust model that provides a way to understand and optimize future devices. In this work, for the first time, an electrical equivalent model of a long plasma source (comprising plasma generation, transport and target interaction) was designed, implemented, and validated. System parameters were estimated based on the system geometry and independent measurements. The model reliably reproduces the double ignition (in the quartz chamber and at the treatment site) observed experimentally. Simulations globally agree with measurements taken for various gas gap distances and input voltages. Internal parameters that are difficult to measure, such as the electrical charge at the gas gaps, were inferred. The model can predict leakage current in the body and current at the target site. This work provides a new understanding of endoscopic plasma systems that could be used in the future to ensure patient and operator safety. [ABSTRACT FROM AUTHOR]